Q1 2027 Vimta Labs Ltd Earnings Call Transcript
Key Points
- Vimta Labs Ltd (BOM:524394) reported a year-on-year growth of 13.7% in total income, reaching INR1,129 million for Q1 FY27.
- The company achieved a 16% year-on-year increase in EBITDA, with margins standing at 36.4%, reflecting strong operational efficiency.
- The Pharma Contract Research and Testing services division showed consistent performance with strong year-on-year growth.
- The clinical research operations are showing signs of recovery with healthy inquiries and orders inflows.
- Vimta Labs Ltd (BOM:524394) remains net debt-free with cash and cash equivalents of INR628.2 million, indicating a strong financial position.
- The Food Testing business experienced a decline in import and export-related sample receipts due to ongoing global challenges.
- Operating margins moderated on a quarter-on-quarter basis due to higher facility-related expenses and new labor laws.
- The Environment division has been integrated with the Food division, indicating challenges in maintaining it as a separate entity.
- The company faces challenges from global issues, particularly in the Middle East, which could impact growth.
- There is uncertainty regarding the timeline for significant contributions from the new Biologics segment.
Ladies and gentlemen, good day, and welcome to Vimta Labs Limited Q1 FY27 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Vishal Manchanda from Systematix. Thank you, and over to you, sir.
()-
On behalf of Systematix Institutional Equities, I welcome you to the Q1 FY27 earnings call of Vimta Labs. We thank the Vimta management for giving us an opportunity to host the call. We have with us the senior management of the company represented by Ms. Harita Vasireddi, Managing Director; Mr. Satya Sreenivas Neerukonda, Executive Director; Mr. Siva Rama Krishna, Chief Financial Officer; and Ms. Sujani Vasireddi, Company Secretary.
I'll now hand over the call to the company management for opening remarks.
Thank you, Vishal. Good
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
